Codes / ICD10CM / T45.513A

T45.513A Poisoning by anticoagulants, assault, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by anticoagulants, assault, initial encounter (ICD-10 code T45.513A)

Summary

This condition refers to harmful effects resulting from exposure to anticoagulants due to assault, occurring during the initial encounter for treatment. Anticoagulants are medications that prevent blood clotting, and this code applies when such exposure is intentional and caused by another party, leading to impaired coagulation and potential bleeding complications.

Causes

Exposure to anticoagulants in this context results from intentional administration or ingestion by another individual, typically as part of an assault. This may involve forced ingestion, injection, or other means of exposure without the patient's consent, leading to poisoning.

Risk Factors

  • Proximity to individuals with access to anticoagulant medications.
  • Situations involving conflict or violence where forced exposure is possible.
  • Lack of secure storage of anticoagulants in environments where assault may occur.

Symptoms

  • Unusual or excessive bruising.
  • Prolonged bleeding from minor injuries.
  • Blood in urine, stool, or vomit.
  • Nosebleeds or bleeding gums that are difficult to control.
  • Dizziness, weakness, or fatigue from blood loss.

Diagnosis

Diagnosis involves a detailed patient history to confirm the assault, assessment of clinical signs of bleeding or coagulation abnormalities, and lab tests (e.g., INR, PT/PTT) to evaluate anticoagulant levels and coagulation status. Documentation of the assault and its circumstances is critical.

Treatment Options

Treatment focuses on managing bleeding complications, which may include administering reversal agents (e.g., vitamin K, protamine), supportive care, and addressing any injuries from the assault. The underlying cause (assault) may also require legal or protective interventions.

Prognosis and Follow-Up

Prognosis depends on the severity of bleeding, timely treatment, and the extent of exposure. Follow-up includes monitoring coagulation levels, assessing for delayed complications, and addressing any psychological or physical sequelae from the assault.

Complications

  • Severe or life-threatening bleeding.
  • Organ damage from excessive blood loss.
  • Long-term coagulation disorders.
  • Psychological trauma related to the assault.

Lifestyle & Prevention

Prevention involves securing anticoagulant medications to prevent unauthorized access and avoiding situations where assault is a risk. For individuals at risk of assault, ensuring safe storage and limiting access to others may reduce exposure.

When to Seek Professional Help

Seek immediate medical attention if signs of bleeding (e.g., uncontrolled bruising, blood in bodily fluids) or suspected exposure to anticoagulants due to assault occur. Prompt evaluation is critical to manage complications.

Tips for Medical Coders

Use T45.513A for initial encounters where poisoning by anticoagulants is due to assault. Document the assault circumstances, timing of exposure, and initial treatment to support coding. Ensure the "initial encounter" status is clearly recorded, as this affects code assignment.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T45.513A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.